Therapeutic Biological Products
Products that are obtained from specific organs or tissues said to correspond with the unhealthy organs or tissues of the recipient. Proponents claim that the recipient's body automatically transports the injected cells to the target organs, where they supposedly strengthen them and regenerate their structure. The organs and glands used in cell treatment include brain, pituitary, thyroid, adrenals, thymus, liver, kidney, pancreas, spleen, heart, ovary, testis, and parotid. Several different types of cell or cell extract can be given simultaneously - some practitioners routinely give up to 20 or more at once.
- Recommbinant r dna
- Extracts from living organisms
- macromolecular products
Related Conference of Therapeutic Biological Products
Therapeutic Biological Products Conference Speakers
Recommended Sessions
- Bioequivalence Assessment
- Biologics and Biosimilars
- Biopharmaceuticals
- Biosimilars & Biologics: Clinical Studies & Trials
- Biosimilars & Biologics: Current Challenges
- Biosimilars Analytical Strategies
- Biosimilars: Pharmacovigilance and Safety
- Challenges in Biosimilars Pharmacovigilance
- Clinical Development Of Biosimilars
- Globalization of Biosimilars
- Innovation and Technology for Biosimilar Development
- Pharmaceutical Regulatory Affairs And IPR
- Regulatory Approach for Biosimilars
- Therapeutic Biological Products